RSV604

Code: SML1695-25MG D2-231

Biochem/physiol Actions

RSV604 (RSV-604) is a cell-permeable, non-cytotoxic (CC50 >50 µM) benzodiazepine derivative that is reported to target respiratory syncytial viru...


read more

Your Price
€375.80 25MG
€462.23 inc. VAT

Biochem/physiol Actions

RSV604 (RSV-604) is a cell-permeable, non-cytotoxic (CC50 >50 µM) benzodiazepine derivative that is reported to target respiratory syncytial virus (RSV) nucleoprotein (N) via affinity interaction (Kd = 134 µM) and display similar antiviral potency against 40 clinical human RSV isolates (Ave. EC50 = 800 nM), including both subtypes A and B. Although RSV604 displays host-dependent potency against RSV cellular replication (EC50 = 2 µM/HeLa, 1.8 µM/HEp-2, >50 µM/BHK-21 based on cellular viral F protein level 72 hrs post RSV A2 infection) and release (by >1,000,000-fold/HeLa vs. no effect/BHK-21 72 hrs post infection; [RSV604] = EC90), complete loss of infectivity of released RSV from RSV604-treated cells is observed in both HeLa and BHK-21 cultures. RSV604 is also active against bovine RSV, but inactive toward mouse pneumonia virus, human metapneumovirus or parainfluenza virus types 1 &3 (PIV1 &PIV3).

Packaging

5, 25 mg in glass bottle

assay≥98% (HPLC)
colorwhite
formfilm
Quality Level100
SMILES stringO=C(N1)[C@@H](NC(NC2=CC=CC=C2F)=O)N=C(C3=CC=CC=C3)C4=C1C=CC=C4
solubilityDMSO: 20 mg/mL, clear
storage conditionprotect from light
storage temp.2-8°C
Cas Number676128-63-5
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.